PRKAA2 and Alzheimer disease: Multiple lines of evidence indicate that activation of AMPK could result in detrimental outcomes and that restraining AMPK activity confers neuroprotective effects in certain types of brain injury, such as stroke and Alzheimer’s disease [41, 56].